While randomization is required by regulatory bodies, it is up to the sponsor on how to conduct it. Developing a clinical trial’s effective monitoring plan can be overwhelming. The FDA acknowledges ...

Abstract: Deep neural networks are vulnerable to adversar-ial examples, they can be deceived by adding imperceptible perturbations on benign inputs. Moreover, people exploit the transferability of ...